# Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer

> **NCT00137852** · PHASE2 · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 35 (actual)

## Conditions studied

- Esophageal Cancer

## Interventions

- **DRUG:** Cisplatin
- **DRUG:** Irinotecan
- **DRUG:** Celecoxib
- **PROCEDURE:** Radiation Therapy
- **PROCEDURE:** Esophagectomy

## Key facts

- **NCT ID:** NCT00137852
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-01
- **Primary completion:** 2004-08
- **Final completion:** 2017-09
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2017-09-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00137852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00137852, "Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00137852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*